Home › Companies › LEXICON PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and LEXICON PHARMACEUTICALS INC.’s Form 8-K, filed May 10, 2024 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of May 10, 2024: 5 items on LEXICON PHARMACEUTICALS INC.’s Form 8-K, filed May 10, 2024: 5 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024
Explore LEXICON PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are LEXICON PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 10, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Philippe J. Amouyal | 241,812,501 | -- | -- | 18,607,732 | 29,015,729 | 93% | Not verified | — |
| Elect Director: Lonnel Coats | 247,448,636 | -- | -- | 12,971,597 | 29,015,729 | 95% | Not verified | — |
| Elect Director: Diane E. Sullivan | 259,435,040 | -- | -- | 985,193 | 29,015,729 | 99.6% | Not verified | — |
| 2. Ratification and approval of the the Company's Sixth Amended and Restated Certificate of Incorporation | 160,676,391 | 1,433,806 | 211,035 | -- | -- | 99.1% | Not verified | — |
| 4. Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2024 | 286,136,766 | 2,884,465 | 414,731 | -- | -- | 99.0% | Not verified | — |
Source: LEXICON PHARMACEUTICALS INC., Form 8-K, filed with the SEC on May 10, 2024 — read the filing on EDGAR.
Each item below shows how the 109 asset managers that disclosed a LEXICON PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of LEXICON PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
99.6% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Diane E. Sullivan
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Diane E. Sullivan”): 259,435,040 for, 985,193 withheld, per its Form 8-K filed May 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.6% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 12,324,218 for, 8,867 withheld.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 592,515 | 0 | 0 | 0 | For |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 60,801 | 0 | 0 | 0 | For |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 47,381 | 0 | 0 | 0 | For |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 33,538 | 0 | 0 | 0 | For |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 26,469 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,945 | 0 | 0 | 0 | For |
| DWS | 14,403 | 0 | 0 | 0 | For |
| Principal | 10,534 | 0 | 0 | 0 | For |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Lonnel Coats
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Lonnel Coats”): 247,448,636 for, 12,971,597 withheld, per its Form 8-K filed May 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 11,489,113 for, 843,672 withheld, 300 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 592,515 | Withhold |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 0 | 0 | 0 | 60,801 | Withhold |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 47,381 | Withhold |
| Invesco | 0 | 0 | 0 | 38,591 | Withhold |
| ProShares | 0 | 0 | 0 | 33,538 | Withhold |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 9,582 | 0 | 0 | 16,887 | Mixed |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 14,945 | Withhold |
| DWS | 0 | 0 | 0 | 14,403 | Withhold |
| Principal | 0 | 0 | 0 | 10,534 | Withhold |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 3 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Philippe J. Amouyal
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Philippe J. Amouyal”): 241,812,501 for, 18,607,732 withheld, per its Form 8-K filed May 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 8,154,872 for, 4,151,277 withheld, 26,936 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 0 | 2,813,804 | Withhold |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 592,515 | Withhold |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 240,312 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 159,505 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 76,516 | Withhold |
| ETFis Series Trust I | 0 | 0 | 0 | 60,801 | Withhold |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 47,381 | Withhold |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 33,538 | Withhold |
| Pacific Life | 0 | 0 | 0 | 32,246 | Withhold |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 0 | 26,636 | 0 | Abstain |
| Brighthouse | 9,582 | 0 | 0 | 16,887 | Mixed |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 14,945 | Withhold |
| DWS | 0 | 0 | 0 | 14,403 | Withhold |
| Principal | 0 | 0 | 0 | 10,534 | Withhold |
| Voya | 0 | 0 | 0 | 9,063 | Withhold |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Ratification and approval of the Company's Sixth Amended and Restated Certificate of Incorporation
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“2. Ratification and approval of the the Company's Sixth Amended and Restated Certificate of Incorporation”): 160,676,391 for, 1,433,806 against, per its Form 8-K filed May 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 12,333,085 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 592,515 | 0 | 0 | 0 | For |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 60,801 | 0 | 0 | 0 | For |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 47,381 | 0 | 0 | 0 | For |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 33,538 | 0 | 0 | 0 | For |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 26,469 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,945 | 0 | 0 | 0 | For |
| DWS | 14,403 | 0 | 0 | 0 | For |
| Principal | 10,534 | 0 | 0 | 0 | For |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Combines 5 wordings of this item as funds reported it.
91% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 1,204,203 | 0 | 0 | Against |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 592,515 | 0 | 0 | 0 | For |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 20,371 | 219,941 | 0 | 0 | Mixed |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 60,801 | 0 | 0 | 0 | For |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 0 | 47,381 | 0 | 0 | Against |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 33,538 | 0 | 0 | 0 | For |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 26,469 | 0 | 0 | 0 | For |
| SEI | 0 | 17,105 | 0 | 0 | Against |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,945 | 0 | 0 | 0 | For |
| DWS | 14,403 | 0 | 0 | 0 | For |
| Principal | 10,534 | 0 | 0 | 0 | For |
| Voya | 9,063 | 0 | 0 | 0 | For |
| Texas Capital Funds Trust | 8,895 | 0 | 0 | 0 | For |
Fund voting reports, all 36 managers: 10,807,937 for, 1,497,498 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Point72 | 9,216,600 | 0 | 0 | 0 | For |
| Fidelity | 8,502,327 | 0 | 0 | 0 | For |
| BlackRock | 2,227,023 | 7,099 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,771,810 | 0 | 0 | 0 | For |
| State Street | 1,397,255 | 349 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 0 | 804,111 | 0 | 0 | Against |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| Nuveen | 594,382 | 0 | 0 | 0 | For |
| Wellington | 0 | 568,106 | 0 | 0 | Against |
| PINNACLE ASSOCIATES LTD | 531,690 | 0 | 0 | 0 | For |
| Northern Trust | 464,397 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 219,941 | 0 | 0 | Against |
| JPMorgan | 211,974 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 197,839 | 0 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 0 | 175,849 | 0 | 0 | Against |
| Vanguard | 105,171 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 101,332 | 0 | 0 | 0 | For |
| BBR PARTNERS, LLC | 100,000 | 0 | 0 | 0 | For |
| Cerity Partners LLC | 0 | 95,512 | 0 | 0 | Against |
| GREAT POINT PARTNERS LLC | 92,165 | 0 | 0 | 0 | For |
| Natixis | 0 | 86,788 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 72,285 | 0 | 0 | 0 | For |
| Goldman Sachs | 62,185 | 0 | 0 | 0 | For |
| Invesco | 62,178 | 0 | 0 | 0 | For |
| Two Sigma | 60,442 | 0 | 0 | 0 | For |
Institutional-manager reports, all 89 managers: 26,688,736 for, 2,138,925 against, 3,300 withheld. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.0% Majority: yes · of votes cast
Description as filed by funds: Ratification and approval of the appointment of Ernst & Young LLP as the Company's independent auditors for the fiscal year ending December 31, 2024
LEXICON PHARMACEUTICALS INC.’s own tally for this item (“4. Ratification and approval of the appointment of Ernst & Young LLP as Company's independent auditors for the fiscal year ending December 31, 2024”): 286,136,766 for, 2,884,465 against, per its Form 8-K filed May 10, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 37 asset managers below reported 12,333,085 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 3,496,030 | 0 | 0 | 0 | For |
| BlackRock | 2,813,804 | 0 | 0 | 0 | For |
| Vanguard | 2,190,262 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,204,203 | 0 | 0 | 0 | For |
| Charles Schwab | 616,297 | 0 | 0 | 0 | For |
| TIAA | 592,515 | 0 | 0 | 0 | For |
| JPMorgan | 478,651 | 0 | 0 | 0 | For |
| Equitable | 240,312 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 159,505 | 0 | 0 | 0 | For |
| Lincoln Financial | 76,516 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 60,801 | 0 | 0 | 0 | For |
| Northern Trust | 51,996 | 0 | 0 | 0 | For |
| Dimensional | 47,381 | 0 | 0 | 0 | For |
| Invesco | 38,591 | 0 | 0 | 0 | For |
| ProShares | 33,538 | 0 | 0 | 0 | For |
| Pacific Life | 32,246 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 27,650 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 26,636 | 0 | 0 | 0 | For |
| Brighthouse | 26,469 | 0 | 0 | 0 | For |
| SEI | 17,105 | 0 | 0 | 0 | For |
| Prudential/PGIM | 15,609 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 14,945 | 0 | 0 | 0 | For |
| DWS | 14,403 | 0 | 0 | 0 | For |
| Principal | 10,534 | 0 | 0 | 0 | For |
| Voya | 9,063 | 0 | 0 | 0 | For |
Showing the 25 largest of 37 asset managers. See all 37 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 246,236,753 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 1.42% |
| 2 | BlackRock | 1.14% |
| 3 | Vanguard | 0.89% |
| 4 | Columbia Threadneedle | 0.49% |
| 5 | Charles Schwab | 0.25% |
| 6 | TIAA | 0.24% |
| 7 | JPMorgan | 0.19% |
| 8 | Equitable | 0.10% |
| 9 | QUANTITATIVE MASTER SERIES LLC | 0.06% |
| 10 | Lincoln Financial | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Point72 | 3.74% |
| 2 | Fidelity | 3.45% |
| 3 | BlackRock | 0.91% |
| 4 | ORBIMED ADVISORS LLC | 0.72% |
| 5 | State Street | 0.57% |
| 6 | PNC BANK, NATIONAL ASSOCIATION | 0.33% |
| 7 | Charles Schwab | 0.25% |
| 8 | Nuveen | 0.24% |
| 9 | Wellington | 0.23% |
| 10 | PINNACLE ASSOCIATES LTD | 0.22% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Invus, L.P., Invus Public Equities, L.P., Invus US Partners, LLC and Artal International S | 73.32% | DEF14A |
| FMR (Fidelity) | 15.71% | 13F |
| FMR LLC | 15.00% | DEF14A |
| Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P., Biotechnology Value Tra | 9.92% | DEF14A |
| Vanguard Group | 3.87% | 13F |
| Raymond Debbane | 2.76% | DEF14A |
| BlackRock | 1.38% | 13F |
| Geode Capital | 0.97% | 13F |
| State Street | 0.81% | 13F |
| Lonnel Coats | 0.45% | DEF14A |
Percentages above are of 246,236,753 shares outstanding, as reported by LEXICON PHARMACEUTICALS INC. on its Form 10-Q dated April 29, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from LEXICON PHARMACEUTICALS INC.’s 10-Q dated April 29, 2024. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At LEXICON PHARMACEUTICALS INC.'s shareholder meeting held May 10, 2024, in the 2023-2024 proxy season, 109 asset managers reported how they voted in their SEC Form N-PX filings, covering 807 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. LEXICON PHARMACEUTICALS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Advisory vote to approve the compensation paid to the Company's named executive officers — the reporting funds and managers cast 91% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
LEXICON PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page).
Download data (CSV): ballot items · votes by manager · column guide.